| Neurotransmitter deficits from frontotemporal lobar degeneration AG Murley, JB Rowe Brain 141 (5), 1263-1285, 2018 | 145 | 2018 |
| Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes AG Murley, I Coyle-Gilchrist, MA Rouse, PS Jones, W Li, J Wiggins, ... Brain 143 (5), 1555-1571, 2020 | 123 | 2020 |
| GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition AG Murley, MA Rouse, PS Jones, R Ye, FH Hezemans, C O’Callaghan, ... Brain 143 (11), 3449-3462, 2020 | 60 | 2020 |
| Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson’s disease C O’Callaghan, FH Hezemans, R Ye, C Rua, PS Jones, AG Murley, ... Brain 144 (8), 2513-2526, 2021 | 59 | 2021 |
| Reduced glutamate turnover in the putamen is linked with automatic habits in human cocaine addiction KD Ersche, TV Lim, AG Murley, C Rua, MM Vaghi, TL White, GB Williams, ... Biological psychiatry 89 (10), 970-979, 2021 | 44 | 2021 |
| Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity SS Kaalund, L Passamonti, KSJ Allinson, AG Murley, TW Robbins, ... Acta neuropathologica communications 8, 1-11, 2020 | 36 | 2020 |
| GABAergic cortical network physiology in frontotemporal lobar degeneration NE Adams, LE Hughes, MA Rouse, HN Phillips, AD Shaw, AG Murley, ... Brain 144 (7), 2135-2145, 2021 | 27 | 2021 |
| Incidence of syndromes associated with frontotemporal lobar degeneration in 9 European countries G Logroscino, M Piccininni, C Graff, O Hardiman, AC Ludolph, F Moreno, ... JAMA neurology 80 (3), 279-286, 2023 | 24 | 2023 |
| GABA-ergic dynamics in human frontotemporal networks confirmed by pharmaco-magnetoencephalography NE Adams, LE Hughes, HN Phillips, AD Shaw, AG Murley, D Nesbitt, ... Journal of Neuroscience 40 (8), 1640-1649, 2020 | 23 | 2020 |
| Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes FH Hezemans, N Wolpe, C O’Callaghan, R Ye, C Rua, PS Jones, ... PLoS Computational Biology 18 (5), e1010079, 2022 | 20 | 2022 |
| Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes AG Murley, MA Rouse, ITS Coyle-Gilchrist, PS Jones, W Li, J Wiggins, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (7), 737-744, 2021 | 20 | 2021 |
| Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants D Street, M Malpetti, T Rittman, BCP Ghosh, AG Murley, I Coyle-Gilchrist, ... Brain Communications 3 (3), fcab206, 2021 | 14 | 2021 |
| Proton magnetic resonance spectroscopy in frontotemporal lobar degeneration-related syndromes AG Murley, KA Tsvetanov, MA Rouse, PS Jones, K Sværke, W Li, ... Neurobiology of aging 111, 64-70, 2022 | 13 | 2022 |
| Heteroplasmic mitochondrial DNA mutations in frontotemporal lobar degeneration Y Nie, A Murley, Z Golder, JB Rowe, K Allinson, PF Chinnery Acta Neuropathologica 143 (6), 687-695, 2022 | 12 | 2022 |
| Characterizing cerebral metabolite profiles in anorexia and bulimia nervosa and their associations with habitual behavior ML Westwater, AG Murley, KMJ Diederen, TA Carpenter, H Ziauddeen, ... Translational psychiatry 12 (1), 103, 2022 | 11 | 2022 |
| Co‐occurrence of apathy and impulsivity in progressive supranuclear palsy ZQ Kok, AG Murley, T Rittman, J Rowe, L Passamonti Movement Disorders Clinical Practice 8 (8), 1225-1233, 2021 | 11 | 2021 |
| Metabolomic changes associated with frontotemporal lobar degeneration syndromes AG Murley, PS Jones, I Coyle Gilchrist, L Bowns, J Wiggins, KA Tsvetanov, ... Journal of neurology 267, 2228-2238, 2020 | 11 | 2020 |
| Effect of ethnicity and socioeconomic status on vascular access provision and performance in an urban NHS hospital T Wilmink, A Wijewardane, K Lee, A Murley, L Hollingworth, S Powers, ... Clinical kidney journal 10 (1), 62-67, 2017 | 8 | 2017 |
| Neurophysiological consequences of synapse loss in progressive supranuclear palsy NE Adams, A Jafarian, A Perry, MA Rouse, AD Shaw, AG Murley, ... Brain 146 (6), 2584-2594, 2023 | 7 | 2023 |
| Should patients be on antithrombotic medication for their first arteriovenous fistulae? A Murley, A Wijewardane, T Wilmink, J Baharani The journal of vascular access 17 (2), 118-123, 2016 | 7 | 2016 |
